SHANGHAI (Reuters) - High-level Chinese staff at British drugmaker GlaxoSmithKline Plc are being investigated by police in the south-central Chinese city of Changsha on suspicion of unspecified economic crimes, the official Xinhua News Agency reported.
The Xinhua report on Sunday did not state the number of employees under investigation or give any further details.
Repeated calls to the Changsha police were unanswered on Monday.
A GlaxoSmithKline (GSK) spokeswoman in London said investigations by Chinese authorities into the firm's operations in China were ongoing, but added it was unclear what the investigations were about.
She said Chinese authorities had visited the company's sites in Beijing, Shanghai and Changsha.
Last month, GSK fired its head of research and development in China after discovering a study by some of its Chinese scientists contained misrepresentations of data.
(Reporting by Melanie Lee; Additional reporting by Adam Jourdan in London; Editing by Mark Potter)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app